Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ccdc117 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCDC117 mRNA | CTD | PMID:36331819 | Ccdc117 | Mouse | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CCDC117 mRNA | CTD | PMID:22206623 | Ccdc117 | Mouse | 1,3-dinitrobenzene | decreases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in decreased expression of CCDC117 mRNA | CTD | PMID:21983209 | Ccdc117 | Mouse | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31388691 | Ccdc117 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCDC117 mRNA | CTD | PMID:21215274 | Ccdc117 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCDC117 mRNA | CTD | PMID:32109520 and PMID:33387578 | Ccdc117 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCDC117 mRNA | CTD | PMID:21570461 | Ccdc117 | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | Ccdc117 | Mouse | 2-methylcholine | affects expression | ISO | CCDC117 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of CCDC117 mRNA | CTD | PMID:21179406 | Ccdc117 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC117 mRNA | CTD | PMID:28628672 | Ccdc117 | Mouse | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of CCDC117 mRNA | CTD | PMID:28973697 | Ccdc117 | Mouse | acetamide | decreases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of CCDC117 mRNA | CTD | PMID:31881176 | Ccdc117 | Mouse | acrylamide | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of CCDC117 mRNA | CTD | PMID:28959563 | Ccdc117 | Mouse | acrylamide | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of CCDC117 mRNA | CTD | PMID:32763439 | Ccdc117 | Mouse | arsenite(3-) | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CCDC117 mRNA] | CTD | PMID:32406909 | Ccdc117 | Mouse | benzo[a]pyrene | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CCDC117 mRNA | CTD | PMID:20064835 | Ccdc117 | Mouse | benzo[a]pyrene | decreases methylation | ISO | CCDC117 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CCDC117 promoter | CTD | PMID:27901495 | Ccdc117 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCDC117 mRNA | CTD | PMID:22228805 | Ccdc117 | Mouse | Benzo[k]fluoranthene | decreases expression | EXP | | 6480464 | benzo(k)fluoranthene results in decreased expression of CCDC117 mRNA | CTD | PMID:26377693 | Ccdc117 | Mouse | bisphenol A | decreases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CCDC117 mRNA | CTD | PMID:25181051 | Ccdc117 | Mouse | bisphenol A | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CCDC117 mRNA | CTD | PMID:34947998 | Ccdc117 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCDC117 mRNA | CTD | PMID:33221593 | Ccdc117 | Mouse | bisphenol A | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC117 mRNA | CTD | PMID:28628672 | Ccdc117 | Mouse | butanal | decreases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CCDC117 mRNA | CTD | PMID:26079696 | Ccdc117 | Mouse | cadmium dichloride | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CCDC117 mRNA | CTD | PMID:19010381 | Ccdc117 | Mouse | caffeine | affects phosphorylation | ISO | CCDC117 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of CCDC117 protein | CTD | PMID:35688186 | Ccdc117 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of CCDC117 mRNA | CTD | PMID:25620056 | Ccdc117 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CCDC117 mRNA | CTD | PMID:20938992 | Ccdc117 | Mouse | cisplatin | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CCDC117 mRNA | CTD | PMID:27392435 | Ccdc117 | Mouse | cobalt dichloride | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of CCDC117 mRNA | CTD | PMID:24386269 | Ccdc117 | Mouse | copper(II) sulfate | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CCDC117 mRNA | CTD | PMID:19549813 | Ccdc117 | Mouse | coumestrol | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA | CTD | PMID:19167446 | Ccdc117 | Mouse | dexamethasone | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC117 mRNA | CTD | PMID:28628672 | Ccdc117 | Mouse | Dibutyl phosphate | affects expression | ISO | CCDC117 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CCDC117 mRNA | CTD | PMID:37042841 | Ccdc117 | Mouse | doxorubicin | decreases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CCDC117 mRNA | CTD | PMID:29803840 | Ccdc117 | Mouse | enzyme inhibitor | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CCDC117 protein | CTD | PMID:23301498 | Ccdc117 | Mouse | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of CCDC117 mRNA | CTD | PMID:35436446 | Ccdc117 | Mouse | ethyl methanesulfonate | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of CCDC117 mRNA | CTD | PMID:23649840 | Ccdc117 | Mouse | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of CCDC117 mRNA | CTD | PMID:34813904 | Ccdc117 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CCDC117 mRNA | CTD | PMID:20938992 | Ccdc117 | Mouse | FR900359 | decreases phosphorylation | ISO | CCDC117 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of CCDC117 protein | CTD | PMID:37730182 | Ccdc117 | Mouse | gallic acid | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Gallic Acid results in increased expression of CCDC117 mRNA | CTD | PMID:34408198 | Ccdc117 | Mouse | gentamycin | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CCDC117 mRNA | CTD | PMID:33387578 | Ccdc117 | Mouse | indometacin | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC117 mRNA | CTD | PMID:28628672 | Ccdc117 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CCDC117 mRNA | CTD | PMID:20938992 | Ccdc117 | Mouse | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of CCDC117 mRNA | CTD | PMID:21829687 | Ccdc117 | Mouse | leflunomide | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of CCDC117 mRNA | CTD | PMID:24136188 | Ccdc117 | Mouse | methamphetamine | multiple interactions | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CCDC117 mRNA | CTD | PMID:19564919 | Ccdc117 | Mouse | methamphetamine | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of CCDC117 mRNA | CTD | PMID:19564919 | Ccdc117 | Mouse | methyl methanesulfonate | increases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CCDC117 mRNA | CTD | PMID:23649840 | Ccdc117 | Mouse | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of CCDC117 mRNA | CTD | PMID:21543283 | Ccdc117 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CCDC117 mRNA | CTD | PMID:17562736 | Ccdc117 | Mouse | pentachlorophenol | increases expression | EXP | | 6480464 | Pentachlorophenol results in increased expression of CCDC117 mRNA | CTD | PMID:23892564 | Ccdc117 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCDC117 mRNA | CTD | PMID:36331819 | Ccdc117 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CCDC117 mRNA | CTD | PMID:19270015 | Ccdc117 | Mouse | phenobarbital | decreases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Phenobarbital results in decreased expression of CCDC117 mRNA | CTD | PMID:19162173 | Ccdc117 | Mouse | resveratrol | multiple interactions | ISO | CCDC117 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA | CTD | PMID:19167446 | Ccdc117 | Mouse | resveratrol | multiple interactions | EXP | | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CCDC117 mRNA] | CTD | PMID:31298478 | Ccdc117 | Mouse | SCH 23390 | multiple interactions | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CCDC117 mRNA | CTD | PMID:19564919 | Ccdc117 | Mouse | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of CCDC117 mRNA | CTD | PMID:19073995 | Ccdc117 | Mouse | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC117 mRNA | CTD | PMID:21641980 | Ccdc117 | Mouse | testosterone | decreases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CCDC117 mRNA | CTD | PMID:33359661 | Ccdc117 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CCDC117 mRNA | CTD | PMID:31919559 | Ccdc117 | Mouse | thioacetamide | increases expression | ISO | Ccdc117 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CCDC117 mRNA | CTD | PMID:34492290 | Ccdc117 | Mouse | titanium dioxide | multiple interactions | EXP | | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CCDC117 mRNA] | CTD | PMID:31298478 | Ccdc117 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CCDC117 mRNA | CTD | PMID:31298478 | Ccdc117 | Mouse | triphenyl phosphate | affects expression | ISO | CCDC117 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CCDC117 mRNA | CTD | PMID:37042841 | Ccdc117 | Mouse | valproic acid | decreases expression | ISO | CCDC117 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CCDC117 mRNA | CTD | PMID:23179753 | |